Genomic Cancer Clinical Trials Initiative
Client: National Technical Service funded by Cancer Australia
Project duration: 36 months
The Genomic Cancer Clinical Trials Initiative (GCCTI) is funded by the Australian Government through Cancer Australia. The aim of the GCCTI is to support the 14 national cooperative cancer clinical trials groups (CTGs) funded under Cancer Australia’s Support for Cancer Clinical Trials program to develop cancer clinical trial protocols (grant applications each year) for studies involving two or more cancer types and two or more cooperative trials groups.
ZEST Health Strategies in partnership with the NHMRC Clinical Trials Centre (CTC) has delivered the GCCTI since 2013. The GCCTI through this partnership has successfully submitted four grant applications, of which three have been funded through national research funding streams.
GCCTI has been recognised as a platform which provides the opportunity and encourages engagement with clinical researchers across the sector to enhance trial concepts and ideas. This is supported by the extensive experience and complementary capabilities of both organisations in effective stakeholder engagement and delivery of scientific technical expertise.
For more information about the GCCTI, please visit: gccti.org.au
Project team: Sue Sinclair | Kathryn Lim